Martha Stewart Living Omnimedia, Inc. : an accusation of insider trading (A) / Arianne R. Westby, Mary P. Moulton, James S. O'Rourke.
Domestic advice and home products maven Martha Stewart is accused of selling nearly 4,000 shares of ImClone Systems, Inc. stock shares, just ahead of a public announcement that the companys promising new drug, Erbitux, has failed FDA clinical testing. Accusations of insider trading, based on her spe...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Ebook |
| Language: | English |
| Published: |
London :
SAGE Publications Ltd,
2017.
|
| Series: | SAGE Knowledge. Cases.
|
| Subjects: | |
| Online Access: | SAGE |
| Summary: | Domestic advice and home products maven Martha Stewart is accused of selling nearly 4,000 shares of ImClone Systems, Inc. stock shares, just ahead of a public announcement that the companys promising new drug, Erbitux, has failed FDA clinical testing. Accusations of insider trading, based on her special relationships with ImClone CEO Samuel Waksal and Merrill Lynch broker Peter Bacanovic, threaten her own companys reputation, share price, and market position. Can Martha Stewart Living Omnimedia survive accusations of misconduct or the downfall of its namesake? |
|---|---|
| Item Description: | Originally published: Westby, A. R., Moulton, M. P., & ORourke, J. S. (2002). Martha Stewart Living Omnimedia, Inc.: An accusation of insider trading (A). 02-15 (A). Notre Dame, IN: The Eugene D. Fanning Center for Business Communication, Mendoza College of Business, University of Notre Dame. |
| Physical Description: | 1 online resource : illustrations. |
| ISBN: | 152640723X 9781526407238 |